Back to News
Market Impact: 0.25

Benjamin Graham Detailed Fundamental Analysis

ISRGNDAQ
Company FundamentalsCorporate EarningsAnalyst InsightsHealthcare & Biotech
Benjamin Graham Detailed Fundamental Analysis

Validea's guru fundamental report rates Intuitive Surgical Inc. (ISRG), a large-cap growth stock in Medical Equipment & Supplies, at 71% using its Benjamin Graham-based 'Value Investor' model. While ISRG demonstrates strong underlying fundamentals, passing criteria such as sales, debt, and long-term EPS growth, it fails the critical valuation tests for Price/Earnings and Price/Book ratios, which are central to Graham's deep value methodology. This score places ISRG below the threshold typically indicating significant interest for this specific investment strategy.

Analysis

Intuitive Surgical Inc. (ISRG), a large-cap growth stock in the Medical Equipment & Supplies industry, presents a mixed profile according to a Validea analysis based on Benjamin Graham's value investing principles. The firm scores 71%, which is below the 80% threshold typically indicating model interest. The analysis reveals a clear dichotomy: ISRG exhibits strong underlying business fundamentals, passing criteria for sales performance, current ratio, low long-term debt relative to net current assets, and solid long-term EPS growth. However, it explicitly fails the core valuation tests central to the Graham methodology, namely the Price-to-Earnings (P/E) and Price-to-Book (P/B) ratios. This indicates that while the company's operational health and growth trajectory are robust, its current market valuation is too high to be considered an attractive opportunity from a deep value perspective.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.00

Ticker Sentiment

ISRG0.25
NDAQ0.00

Key Decisions for Investors

  • Strict value investors following Graham's principles should exercise caution, as the stock's high P/E and P/B ratios make it unattractive despite its strong operational fundamentals.
  • Growth-oriented investors may find the confirmed strong long-term EPS growth and sales performance appealing, but must acknowledge the significant valuation premium and associated risk.
  • Investors should monitor ISRG for a potential price correction, as a lower entry point could align its robust fundamentals with a more reasonable valuation, presenting a more compelling opportunity.